leukemia treatment

TAMPA, Fla., June 15, 2026 TuHURA Biosciences, Inc. has announced the filing of an Investigational New Drug (IND) application...

HOUSTON, May 15, 2026 Moleculin Biotech reported first quarter 2026 financial results while advancing its pivotal MIRACLE Phase 2B/3...

PRINCETON, N.J. and TOKYO, May 13, 2026 Taiho Oncology and Taiho Pharmaceutical announced that the U.S. Food and Drug...

BOULDER, Colo., May 12, 2026 Enliven Therapeutics announced new positive clinical findings from its ongoing Phase 1 ENABLE trial...